ClinConnect ClinConnect Logo
Search / Trial NCT05109780

Feasibility of "EmoGuía" to Guide and Personalize Psychological Treatments

Launched by UNIVERSITAT JAUME I · Oct 27, 2021

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

My Emi, Emotional Wellbeing Transdiagnostic Approach Emotional Disorder Unified Protocol

ClinConnect Summary

This clinical trial is exploring a new app called "EmoGuía" that aims to help adults with emotional disorders manage their treatment more effectively. The goal of the study is to see if this app can successfully track patients' progress while they engage in an online psychological program designed to address various emotional challenges. The trial is currently not recruiting participants, but it will be focusing on adults aged 18 and older who have certain levels of anxiety or depression, as well as those showing specific emotional difficulties.

To be eligible for the study, participants must be able to read and understand Spanish, have internet access on both a computer and a mobile phone, and be willing to sign an online consent form. However, individuals under 18, those with severe mental health issues, or those currently receiving treatment for the same emotional problems will not be able to participate. If you join the study, you can expect to use the EmoGuía app to monitor your feelings and experiences as you work through the online program, helping you and your healthcare providers better understand your emotional health journey.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. age ≥18 years
  • 2. showing problematic levels (one standard deviation above or below the mean) in at least one of the 9 transdiagnostic dimensions of the Multidimensional Emotional Disorders Inventory (MEDI; Osma et al., 2021; Rosellini \& Brown, 2019) or having moderate-to-severe anxiety (scores ≥8) or depressive symptoms (scores ≥5), as reported in the Overall Anxiety Severity and Impairment Scale (OASIS) and the Overall Depression Severity and Impairment Scale (ODSIS) (Mira et al., 2019)
  • 3. having the ability to read and understand Spanish
  • 4. having a computer and a mobile phone Internet access
  • 5. signing the online informed consent.
  • Exclusion criteria:
  • 1. age \<18
  • 2. severe mental health problems
  • 3. high suicide risk
  • 4. receiving psychological treatment for the same ED emotional problem targeted by our study at the same time the current study is being conducted
  • 5. \<8 in OASIS and \<5 in ODSIS, or non-problematic scores in the MEDI
  • 6. have changes and/or increases in pharmacological treatment during the study (stable medication will be accepted).

About Universitat Jaume I

Universitat Jaume I (UJI) is a leading academic institution located in Spain, dedicated to advancing knowledge and innovation through research and education. With a strong emphasis on interdisciplinary collaboration, UJI conducts clinical trials aimed at addressing pressing health challenges and improving patient outcomes. The university's commitment to ethical standards and rigorous scientific methodologies ensures the integrity and reliability of its research endeavors. By fostering partnerships with healthcare professionals and industry stakeholders, UJI aims to translate research findings into practical applications that benefit society.

Locations

Patients applied

0 patients applied

Trial Officials

Patricia Gual- Montolio

Study Chair

Universitat Jaume I

Juana Maria Bretón-López

Study Chair

Universitat Jaume I

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials